Prevalence and correlates of illicit and non-medical use of psychotropic drugs in Japan

Social Psychiatry and Psychiatric Epidemiology

Volumn 44, Issue 9, 2009, Pages 777-783

  Tominaga, Mayumi ^a   Kawakami, Norito ^a   Ono, Yutaka ^b   Nakane, Yoshibumi ^c   Nakamura, Yoshikazu ^d   Tachimori, Hisateru ^e   Iwata, Noboru ^f   Uda, Hidenori ^g   Nakane, Hideyuki ^h   Watanabe, Makoto ^d   Naganuma, Yoichi ^e   Furukawa, Toshiaki A ⁱ   Hata, Yukihiro ^j   Kobayashi, Masayo ^d   Miyake, Yuko ^e   Takeshima, Tadashi ^e   Kikkawa, Takehiko ^k  

^a UNIVERSITY OF TOKYO   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

^d JICHI MEDICAL UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^g Soo Branch   (Japan)

^h NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

ⁱ NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^j KAGOSHIMA UNIVERSITY   (Japan)

^k CHUBU GAKUIN UNIVERSITY   (Japan)

more..

Author keywords

CIDI; Descriptive epidemiology; Druguse; Prevalence; WMH surveys

Indexed keywords

ANALGESIC AGENT; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; PSYCHOTROPIC AGENT; TRANQUILIZER;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG MISUSE; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; INTERMITTENT EXPLOSIVE DISORDER; JAPAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; MOOD DISORDER; PREVALENCE;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; ALCOHOL-RELATED DISORDERS; ANXIETY DISORDERS; COHORT STUDIES; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HEALTH SURVEYS; HUMANS; IMPULSE CONTROL DISORDERS; JAPAN; MALE; MIDDLE AGED; MOOD DISORDERS; PRESCRIPTION DRUGS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; URBAN POPULATION;

EID: 69849089792     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-009-0499-1     Document Type: Article

References (22)

1. Aguilar-Gaxiola S, Medina-Mora ME, Magaña CG et al (2006) Illicit drug use research in Latin America: Epidemiology, service use, and HIV. Drug Alcohol Depend 84S:S85-S93
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). American Psychiatric Association, Washington, DC
3. Compton WM, Volkow ND (2006) Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 83S:S4-S7
4. Degenhardt L, Chiu WT, Sampson N, Kessler RC, Anthony JC (2007) Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003. Drug Alcohol Depend 90: 210-223
5. Degenhardt L, Chiu WT, Sampson N et al (2008) Toward a global view of alcohol, tobacco, cannabis, and cocaine use: Findings from the WHO World Mental Health Surveys. PLoS Med 5:e141
6. Fukui S (1999) Epidemiology of antianxiety and tranquilizing agent dependence in Japan. Nihon Shinkei Seishin Yakurigaku Zasshi 19:209-213 (in Japanese)
7. Grinshpoon A, Marom E, Weizman A, Ponizovsky AM (2007) Psychotropic drug use in Israel: Results from the National Health Survey. Prim Care Companion J Clin Psychiatry 9:356-363
8. Gureje O, Degenhardt L, Olley B et al (2007) A descriptive epidemiology of substance use and substance use disorders in Nigeria during the early 21st century. Drug Alcohol Depend 91:1-9
9. Huang B, Dawson DA, Stinson FS et al (2006) Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry 67:1062-1073
10. Kawakami N, Takeshima T, Ono Y et al (2005) Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: Preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry Clin Neurosci 59:441-452
11. Kessler RC, Ustun TB (2004) The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 13:93-121
12. Medina-Mora ME, Borges G, Fleiz C et al (2006) Prevalence and correlates of drug use disorders in Mexico. Pan Am J Public Health 19:265-276
13. Merikangas KR, Mehta RL, Molnar BE et al (1998) Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addict Behav 23:893-907
14. Ozaki S (1999) Current status of abuse and dependence on medications at psychiatric facilities. Nihon Shinkei Seishin Yakurigaku Zasshi 19:195-198 (in Japanese)
15. Proctor BD, Dalaker J (2002) Current population reports. Poverty in the United States: 2001. US Government Printing Office, Washington, DC
16. Research Triangle Institute (2002) SUDAAN: Professional software for survey data analysis, version 8.0.1. Research Triangle Park, North Carolina
17. Wada K, Kikuchi A, Nakano R, Ozaki S (2004) Current situation on drug abuse in Japan: Using a general population survey and a junior high school students survey. Nihon Arukoru Yakubutsu Igakkai Zasshi 39:28-34 (in Japanese)
18. WHO World Mental Health Survey Consortium (2004) Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA 291:2581-2590
19. Wolter KM (1985) Introduction to variance estimation. Springer, New York
20. World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. World Health Organization, Geneva
21. World Health Organization (2005) Mental Health Atlas 2005. World Health Organization, Geneva
22. Yamamoto J (2004) Recent trends of drug abuse in Japan. Ann NY Acad Sci 1025:430-438